The MHC Class II Transactivator (CIITA): A "Physiologic" Drug Against HIV-1 Replication by Accolla Roberto S, Mortara Lorenzo, Barbaro Andrea, Tosi Giovanna

7he MHC Class II Transactivator (CIITA): A Physiologic Inhibitor of HTLV-2 Retroviral Infection by Casoli Claudio, Mortara Lorenzo, Barbaro Andrea, Pilotti Elisabetta, Tosi Giovanna, Accolla Roberto S

Metabolic and cardiovascular risk in patients with a history of differentiated thyroid carcinoma: A case-controlled cohort study by Giusti Massimo, Mortara Lorenzo, Degrandi Roberta, Cecoli Francesca, Mussap Michele, Rodriguez Guido, Ferone Diego, Minuto Francesco

Get full text

SIV escape mutants in rhesus macaques vaccinated with NEF-derived lipopeptides and challenged with pathogenic SIVmac251 by Mortara Lorenzo, Coutsinos Zoe, Letourneur Franck, Villefroy Pascale, Beyer Christian, Gras-Masse Helene, Guillet Jean-Gerard, Bourgault-Villada Isabelle

Get full text

The immunological basis of tumor therapy by targeted delivery of TNFa to tumor vessels by Zardi Luciano, Accollo Roberto, Castellani Patrizia, Neri Dario, Carnemolla Barbara, Monteghirfo Stefano, Sassi Francesca, Mortara Lorenzo, Balza Enrica, Borsi Laura